S100B and neoplasm: PENVE did not cause a significant reduction of S100B protein expression and release in the control (−5% and −14%), peritumoral (+9% and +11%), UC (+2% and +3%) and tumour biopsy (+4% and −6%) (Figure 3A‐C) (all P not significant) vs untreated control group.